 |
June H. Lee, M.D. | |
|---|---|
| Alma mater | Johns Hopkins University, University of California, Davis |
| Scientific career | |
| Institutions | Genentech, MyoKardia, [1] UCSF, Foresite Labs [2] |
June Lee is an adjunct professor in the UCSF School of Medicine, biotech executive, and medical doctor with expertise in pulmonary, critical care medicine and translational research.
June Lee was born in Seoul, South Korea, and immigrated to United States at age 10. June, her two brothers, and her parents settled in southern California.
She graduated from John F. Kennedy High School in Granada Hills. She developed interest in medicine and science early in part due to a familial hereditary condition. [3] She received her undergraduate degree in chemistry at Johns Hopkins University in 1988, and earned her medical degree at the University of California, Davis in 1992. She performed residency in internal medicine at UCLA and fellowship in pulmonary and critical medicine at UCSF. [4]
Lee served as the medical director of the High-Risk Asthma Clinic at San Francisco General Hospital. [5] She maintained an independent research program prior to Genentech, funded by the American Lung Association, to investigate IL-13 induced transcription, [6] among other pulmonary treatments.
Lee joined the clinical development organization at Genentech initially to help launch a new biologic treatment for asthma (the data from a large respiratory study – TENOR – that resulted in multiple insights into risk factors and demographics for asthma sufferers). [7]
Lee holds a professorship at UCSF in the School of Medicine. [8] She was the director of Early Translational Research at UCSF. [9] From 2011 to 2017, Lee served as the director of the Catalyst Program inside UCSF, which served as an internal incubator for entrepreneurial ideas from faculty, in addition to providing de-risking outsourcing partnerships and educational modules for graduate students. [10]
Lee served as the chief operating officer and chief development officer for MyoKardia. [11] Myokardia was acquired by Bristol Myers Squibb for $13.1 billion in November 2020. [12]
June was the President and Founding CEO of Esker Therapeutics. [13]
She is a member of the board of directors [14] for Novus Therapeutics, [15] GenEdit [16] and serves on the scientific advisory board for Foresite Labs [17] and Aer Therapeutics. She also serves on the advisory board for the Johns Hopkins University Center for Therapeutic Translation.
Lee has been a volunteer member of the Council of Korean Americans since 2013, and currently sits on its board of directors and previously served as chair of the board. [18] She has served previously as chair of the Drug, Device, Discovery, and Development Workgroup of UC BRAID (University of California Biomedical Research Acceleration Integration and Development). [19]
Lee is a fellow of the American College of Chest Physicians.
The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Pulmonology, pneumology or pneumonology is a medical specialty that deals with diseases involving the respiratory tract. It is also known as respirology, respiratory medicine, or chest medicine in some countries and areas.
Arthur D. Levinson is an American businessman and is the current chairman of Apple Inc. (2011–present) and CEO of Calico. He is the former chief executive officer (1995–2009) and chairman (1999–2014) of Genentech.
Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014–2020. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.
Alan Ashworth, FRS is a British molecular biologist, noted for his work on genes involved in cancer susceptibility. He is currently the President of the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, a multidisciplinary research and clinical care organisation that is one of the largest cancer centres in the Western United States. He was previously CEO of the Institute of Cancer Research (ICR) in London.
United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.
Julius H. Comroe, Jr. was a surgeon, medical researcher, author and educator, described by The New York Times as an "award-winning expert on the functions and physiology of the human heart and lungs". His work contributed to advances in respiratory physiology, cardiology, heart and vascular surgery, and the treatment of pulmonary disease, hypertension and high blood pressure.
Ravi Kalhan is the director of the Asthma and COPD Program at Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital.
Nancy Tang Chang, née Tang Nanshan, is a biochemist who cofounded Tanox in 1986 to address medical needs in the areas of allergy, asthma, inflammation and diseases affecting the human immune system. Tanox took an innovative approach in developing an asthma drug that focused on the allergy-related basis of asthma, Xolair. In June 2003, the U.S. Food and Drug Administration (FDA) approved Xolair, the first biotech product cleared for treating those with asthma related to allergies. Tanox was also active in the development of TNX-355, an antibody for the treatment of HIV/AIDS. In 2007, Tanox was sold to Genentech for $919 million. Dr. Chang grew Tanox from an idea to a substantial publicly traded company, doing innovative science. Following her success with Tanox, she has become an angel investor in health-care entrepreneurships and performs philanthropic work in community health-education projects.
Edith A. Pérez is a Puerto Rican hematologist-oncologist. She is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic Alix School of Medicine.
Bruce F. Scharschmidt is an American physician-scientist whose career has spanned academic, business and non-profit sectors. He was a major contributor to the care of patients with liver disease and advancement of liver transplantation.
Jennifer Rubin Grandis is an American otolaryngologist, focusing in general otolaryngology and clinical and translational research. Her research interests include diagnosis and treatment of head and neck cancer. She is a Full professor at the University of California, San Francisco having previously worked as the UPMC Endowed Chair at University of Pittsburgh.
Kirsten Bibbins-Domingo is an American epidemiologist and physician. She is the 17th Editor in Chief of the Journal of the American Medical Association (JAMA) and the JAMA Network. She is Professor of Epidemiology and Biostatistics and the Lee Goldman, MD Endowed Professor of Medicine at University of California, San Francisco. She is a general internist and attending physician at San Francisco General Hospital.
Christine Edry Seidman is the Thomas W. Smith Professor of Medicine at Harvard Medical School and director of the Cardiovascular Genetics Center at Brigham and Women's Hospital. She operates a joint lab with her husband, Jonathan Seidman, where they study genetic mechanisms of heart disease. In recognition of her scientific contributions, she was elected as a fellow of the National Academy of Sciences, American Academy of Arts and Sciences, and National Academy of Medicine.
Esteban González Burchard is an American physician-scientist, a distinguished professor in the School of Pharmacy at University of California at San Francisco,a specialist in gene-environment interactions in asthma and health disparities.
Tina Vivienne Hartert is an American physician and the Lulu H. Owen Endowed Chair in Medicine at Vanderbilt University. She serves as Assistant Vice Chancellor for Translational Science and Director of the Center for Asthma Research. Her research considers asthma and allergic disease. During the COVID-19 pandemic Hartert studied the transmission of coronavirus disease amongst children.
Michelle Asha Albert is an American physician who is the Walter A. Haas Lucie-Stern Endowed Chair in Cardiology and professor of medicine at the University of California, San Francisco. Albert is director of the UCSF Center for the Study of Adversity and Cardiovascular Disease. She is president of the American Heart Association. She served as the president of the Association of Black Cardiologists in 2020–2022 and as president of the Association of University Cardiologists (2021–2022). Albert is an elected member of the National Academy of Medicine and the American Society of Clinical Investigators.
Catherine Reinis Lucey is an American internist, geriatrician, and medical educator.